{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:55:23Z","timestamp":1761519323511,"version":"3.37.3"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,2]],"date-time":"2021-03-02T00:00:00Z","timestamp":1614643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,2]],"date-time":"2021-03-02T00:00:00Z","timestamp":1614643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Regen Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Spinal cord injury (SCI) leads to dramatic impairments of motor, sensory, and autonomic functions of affected individuals. Following the primary injury, there is an increased release of glutamate that leads to excitotoxicity and further neuronal death. Therefore, modulating glutamate excitotoxicity seems to be a promising target to promote neuroprotection during the acute phase of the injury. In this study, we evaluated the therapeutic effect of a FDA approved antiepileptic drug (levetiracetam-LEV), known for binding to the synaptic vesicle protein SV2A in the brain and spinal cord. LEV therapy was tested in two models of SCI\u2014one affecting the cervical and other the thoracic level of the spinal cord. The treatment was effective on both SCI models. Treated animals presented significant improvements on gross and fine motor functions. The histological assessment revealed a significant decrease of cavity size, as well as higher neuronal and oligodendrocyte survival on treated animals. Molecular analysis revealed that LEV acts by stabilizing the astrocytes allowing an effective uptake of the excess glutamate from the extracellular space. Overall, our results demonstrate that Levetiracetam may be a promising drug for acute management of SCI.<\/jats:p>","DOI":"10.1038\/s41536-021-00121-7","type":"journal-article","created":{"date-parts":[[2021,3,2]],"date-time":"2021-03-02T11:04:56Z","timestamp":1614683096000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Levetiracetam treatment leads to functional recovery after thoracic or cervical injuries of the spinal cord"],"prefix":"10.1038","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4208-2011","authenticated-orcid":false,"given":"Rui","family":"Lima","sequence":"first","affiliation":[]},{"given":"Eduardo D.","family":"Gomes","sequence":"additional","affiliation":[]},{"given":"Jorge R.","family":"Cibr\u00e3o","sequence":"additional","affiliation":[]},{"given":"Lu\u00eds A.","family":"Rocha","sequence":"additional","affiliation":[]},{"given":"Rita C.","family":"Assun\u00e7\u00e3o-Silva","sequence":"additional","affiliation":[]},{"given":"Cl\u00e1udia S.","family":"Rodrigues","sequence":"additional","affiliation":[]},{"given":"Andreia","family":"Neves-Carvalho","sequence":"additional","affiliation":[]},{"given":"Susana","family":"Monteiro","sequence":"additional","affiliation":[]},{"given":"Ant\u00f3nio J.","family":"Salgado","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1061-1716","authenticated-orcid":false,"given":"Nuno A.","family":"Silva","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2021,3,2]]},"reference":[{"key":"121_CR1","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.pneurobio.2013.11.002","volume":"114","author":"NA Silva","year":"2014","unstructured":"Silva, N. A., Sousa, N., Reis, R. L. & Salgado, A. J. From basics to clinical: a comprehensive review on spinal cord injury. Prog. Neurobiol. 114, 25\u201357 (2014).","journal-title":"Prog. Neurobiol."},{"key":"121_CR2","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1089\/0897715041269641","volume":"21","author":"E Park","year":"2004","unstructured":"Park, E., Velumian, A. A. & Fehlings, M. G. The role of excitotoxicity in secondary mechanisms of spinal cord injury: a review with an emphasis on the implications for white matter degeneration. J. Neurotrauma 21, 754\u2013774 (2004).","journal-title":"J. Neurotrauma"},{"key":"121_CR3","doi-asserted-by":"publisher","first-page":"9861","DOI":"10.1073\/pnas.0308208101","volume":"101","author":"BA Lynch","year":"2004","unstructured":"Lynch, B. A. et al. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc. Natl Acad. Sci. 101, 9861\u20139866 (2004).","journal-title":"Proc. Natl Acad. Sci."},{"key":"121_CR4","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ejphar.2005.07.029","volume":"520","author":"N Lambeng","year":"2005","unstructured":"Lambeng, N., Gillard, M., Vertongen, P., Fuks, B. & Chatelain, P. Characterization of [3H] ucb 30889 binding to synaptic vesicle protein 2A in the rat spinal cord. Eur. J. Pharmacol. 520, 70\u201376 (2005).","journal-title":"Eur. J. Pharmacol."},{"key":"121_CR5","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1111\/j.1528-1167.2006.01132.x","volume":"48","author":"XF Yang","year":"2007","unstructured":"Yang, X. F., Weisenfeld, A. & Rothman, S. M. Prolonged exposure to levetiracetam reveals a presynaptic effect on neurotransmission. Epilepsia 48, 1861\u20131869 (2007).","journal-title":"Epilepsia"},{"key":"121_CR6","doi-asserted-by":"publisher","first-page":"15268","DOI":"10.1073\/pnas.96.26.15268","volume":"96","author":"KM Crowder","year":"1999","unstructured":"Crowder, K. M. et al. Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A). Proc. Natl Acad. Sci. USA 96, 15268\u201315273 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"121_CR7","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/35087000","volume":"3","author":"T Xu","year":"2001","unstructured":"Xu, T. & Bajjalieh, S. M. SV2 modulates the size of the readily releasable pool of secretory vesicles. Nat. Cell Biol. 3, 691\u2013698 (2001).","journal-title":"Nat. Cell Biol."},{"key":"121_CR8","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.brainres.2007.03.021","volume":"1151","author":"Y Ueda","year":"2007","unstructured":"Ueda, Y. et al. Effect of levetiracetam on molecular regulation of hippocampal glutamate and GABA transporters in rats with chronic seizures induced by amygdalar FeCl3 injection. Brain Res. 1151, 55\u201361 (2007).","journal-title":"Brain Res."},{"key":"121_CR9","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1002\/jnr.21639","volume":"86","author":"A Haghikia","year":"2008","unstructured":"Haghikia, A. et al. Implications of antiinflammatory properties of the anticonvulsant drug levetiracetam in astrocytes. J. Neurosci. Res. 86, 1781\u20131788 (2008).","journal-title":"J. Neurosci. Res."},{"key":"121_CR10","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/j.1476-5381.2010.01038.x","volume":"162","author":"MN Stienen","year":"2011","unstructured":"Stienen, M. N. et al. Anti-inflammatory effects of the anticonvulsant drug levetiracetam on electrophysiological properties of astroglia are mediated via TGF\u03b21 regulation. Br. J. Pharm. 162, 491\u2013507 (2011).","journal-title":"Br. J. Pharm."},{"key":"121_CR11","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/BF02653674","volume":"66","author":"A Schmedes","year":"1989","unstructured":"Schmedes, A. & H\u00f8lmer, G. A new thiobarbituric acid (TBA) method for determining free malondialdehyde (MDA) and hydroperoxides selectively as a measure of lipid peroxidation. J. Am. Oil Chemists\u2019 Soc. 66, 813\u2013817 (1989).","journal-title":"J. Am. Oil Chemists\u2019 Soc."},{"key":"121_CR12","doi-asserted-by":"publisher","first-page":"9525","DOI":"10.1523\/JNEUROSCI.0579-07.2007","volume":"27","author":"C Matute","year":"2007","unstructured":"Matute, C. et al. P2X7 receptor blockade prevents ATP excitotoxicity in oligodendrocytes and ameliorates experimental autoimmune encephalomyelitis. J. Neurosci. 27, 9525\u20139533 (2007).","journal-title":"J. Neurosci."},{"key":"121_CR13","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s00424-010-0809-1","volume":"460","author":"A Lau","year":"2010","unstructured":"Lau, A. & Tymianski, M. Glutamate receptors, neurotoxicity and neurodegeneration. Pfl\u00fcgers Arch.-Eur. J. Physiol. 460, 525\u2013542 (2010).","journal-title":"Pfl\u00fcgers Arch.-Eur. J. Physiol."},{"key":"121_CR14","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1097\/00002826-200109000-00002","volume":"24","author":"RJ Dumont","year":"2001","unstructured":"Dumont, R. J. et al. Acute spinal cord injury, part I: pathophysiologic mechanisms. Clin. Neuropharmacol. 24, 254\u2013264 (2001).","journal-title":"Clin. Neuropharmacol."},{"key":"121_CR15","first-page":"1813","volume":"22","author":"LP Mark","year":"2001","unstructured":"Mark, L. P. et al. Pictorial review of glutamate excitotoxicity: fundamental concepts for neuroimaging. Am. J. Neuroradiol. 22, 1813\u20131824 (2001).","journal-title":"Am. J. Neuroradiol."},{"key":"121_CR16","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1177\/1545968313491007","volume":"27","author":"H Zou","year":"2013","unstructured":"Zou, H. et al. Neuroprotective, neuroplastic, and neurobehavioral effects of daily treatment with levetiracetam in experimental traumatic brain injury. Neurorehab. Neural Rep. 27, 878\u2013888 (2013).","journal-title":"Neurorehab. Neural Rep."},{"key":"121_CR17","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/j.1527-3458.2007.00004.x","volume":"13","author":"T De Smedt","year":"2007","unstructured":"De Smedt, T., Raedt, R., Vonck, K. & Boon, P. Levetiracetam: the profile of a novel anticonvulsant drug\u2014part I: preclinical data. CNS Drug Rev. 13, 43\u201356 (2007).","journal-title":"CNS Drug Rev."},{"key":"121_CR18","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/j.1527-3458.2007.00005.x","volume":"13","author":"T De Smedt","year":"2007","unstructured":"De Smedt, T., Raedt, R., Vonck, K. & Boon, P. Levetiracetam: part II, the clinical profile of a novel anticonvulsant drug. CNS Drug Rev. 13, 57\u201378 (2007).","journal-title":"CNS Drug Rev."},{"key":"121_CR19","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0166-4328(99)00018-2","volume":"103","author":"GD Muir","year":"1999","unstructured":"Muir, G. D. & Whishaw, I. Q. Complete locomotor recovery following corticospinal tract lesions: measurement of ground reaction forces during overground locomotion in rats. Behav. Brain Res. 103, 45\u201353 (1999).","journal-title":"Behav. Brain Res."},{"key":"121_CR20","first-page":"425","volume":"47","author":"S Grillner","year":"1988","unstructured":"Grillner, S. Control of locomotion in vertebrates: spinal and supraspinal mechanisms. Adv. Neurol. 47, 425\u2013453 (1988).","journal-title":"Adv. Neurol."},{"key":"121_CR21","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/0959-4388(94)90139-2","volume":"4","author":"S Rossignol","year":"1994","unstructured":"Rossignol, S. & Dubuc, R. Spinal pattern generation. Curr. Opin. Neurobiol. 4, 894\u2013902 (1994).","journal-title":"Curr. Opin. Neurobiol."},{"key":"121_CR22","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.1749-6632.1998.tb09040.x","volume":"860","author":"LM Jordan","year":"1998","unstructured":"Jordan, L. M. Initiation of Locomotion in Mammals. Ann. N. Y. Acad. Sci. 860, 83\u201393 (1998).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"121_CR23","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1152\/jn.1998.80.3.1245","volume":"80","author":"E Brustein","year":"1998","unstructured":"Brustein, E. & Rossignol, S. Recovery of locomotion after ventral and ventrolateral spinal lesions in the cat. I. Deficits and adaptive mechanisms. J. Neurophysiol. 80, 1245\u20131267 (1998).","journal-title":"J. Neurophysiol."},{"key":"121_CR24","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1046\/j.1460-9568.2000.00987.x","volume":"12","author":"GD Muir","year":"2000","unstructured":"Muir, G. D. & Whishaw, I. Q. Red nucleus lesions impair overground locomotion in rats: a kinetic analysis. Eur. J. Neurosci. 12, 1113\u20131122 (2000).","journal-title":"Eur. J. Neurosci."},{"key":"121_CR25","doi-asserted-by":"publisher","first-page":"4744","DOI":"10.1523\/JNEUROSCI.18-12-04744.1998","volume":"18","author":"WJ Z\u2019Graggen","year":"1998","unstructured":"Z\u2019Graggen, W. J., Metz, G. A., Kartje, G. L., Thallmair, M. & Schwab, M. E. Functional recovery and enhanced corticofugal plasticity after unilateral pyramidal tract lesion and blockade of myelin-associated neurite growth inhibitors in adult rats. J. Neurosci. 18, 4744\u20134757 (1998).","journal-title":"J. Neurosci."},{"key":"121_CR26","volume":"94","author":"C Kathe","year":"2014","unstructured":"Kathe, C. et al. Unilateral pyramidotomy of the corticospinal tract in rats forassessment of neuroplasticity-inducing therapies. J. Vis. Exp 94, e51843 (2014).","journal-title":"J. Vis. Exp"},{"key":"121_CR27","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/0166-4328(95)00209-X","volume":"77","author":"IQ Whishaw","year":"1996","unstructured":"Whishaw, I. Q. & Coles, B. L. Varieties of paw and digit movement during spontaneous food handling in rats: postures, bimanual coordination, preferences, and the effect of forelimb cortex lesions. Behav. Brain Res. 77, 135\u2013148 (1996).","journal-title":"Behav. Brain Res."},{"key":"121_CR28","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1523\/JNEUROSCI.18-07-02777.1998","volume":"18","author":"JW Aldridge","year":"1998","unstructured":"Aldridge, J. W. & Berridge, K. C. Coding of serial order by neostriatal neurons: a \u201cnatural action\u201d approach to movement sequence. J. Neurosci. 18, 2777\u20132787 (1998).","journal-title":"J. Neurosci."},{"key":"121_CR29","volume-title":"Facts and Figures at a Glance.","author":"Center, N. S. C. I. S.","year":"2019","unstructured":"Center, N. S. C. I. S. Facts and Figures at a Glance. (University of Alabama, 2019)."},{"key":"121_CR30","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S0304-3940(01)01884-5","volume":"306","author":"I Niespodziany","year":"2001","unstructured":"Niespodziany, I., Klitgaard, H. & Margineanu, D. G. Levetiracetam inhibits the high-voltage-activated Ca 2+ current in pyramidal neurones of rat hippocampal slices. Neurosci. Lett. 306, 5\u20138 (2001).","journal-title":"Neurosci. Lett."},{"key":"121_CR31","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.neulet.2008.02.076","volume":"436","author":"N Nagarkatti","year":"2008","unstructured":"Nagarkatti, N., Deshpande, L. S. & DeLorenzo, R. J. Levetiracetam Inhibits both ryanodine and IP3 receptor activated calcium induced calcium release in hippocampal neurons in culture. Neurosci. Lett. 436, 289\u2013293 (2008).","journal-title":"Neurosci. Lett."},{"key":"121_CR32","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/S0896-6273(00)81046-6","volume":"24","author":"R Janz","year":"1999","unstructured":"Janz, R., Goda, Y., Geppert, M., Missler, M. & S\u00fcdhof, T. C. SV2A and SV2B function as redundant Ca2+ regulators in neurotransmitter release. Neuron 24, 1003\u20131016 (1999).","journal-title":"Neuron"},{"key":"121_CR33","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.mcn.2007.02.009","volume":"35","author":"M Figiel","year":"2007","unstructured":"Figiel, M., Allritz, C., Lehmann, C. & Engele, J. Gap junctional control of glial glutamate transporter expression. Mol. Cell. Neurosci. 35, 130\u2013137 (2007).","journal-title":"Mol. Cell. Neurosci."},{"key":"121_CR34","doi-asserted-by":"publisher","first-page":"10193","DOI":"10.1523\/JNEUROSCI.19-23-10193.1999","volume":"19","author":"S Duan","year":"1999","unstructured":"Duan, S., Anderson, C. M., Stein, B. A. & Swanson, R. A. Glutamate induces rapid upregulation of astrocyte glutamate transport and cell-surface expression of GLAST. J. Neurosci. 19, 10193\u201310200 (1999).","journal-title":"J. Neurosci."},{"key":"121_CR35","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1385\/NCC:5:1:71","volume":"5","author":"H Wang","year":"2006","unstructured":"Wang, H. et al. Levetiracetam is neuroprotective in murine models of closed head injury and subarachnoid hemorrhage. Neurocrit. Care 5, 71\u201378 (2006).","journal-title":"Neurocrit. Care"},{"key":"121_CR36","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1089\/neu.2015.4131","volume":"33","author":"M Browning","year":"2016","unstructured":"Browning, M. et al. Operation brain trauma therapy: levetiracetam treatment in traumatic brain injury. J. Neurotrauma 33, 581\u2013594 (2016).","journal-title":"J. Neurotrauma"},{"key":"121_CR37","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1080\/08941939.2018.1490828","volume":"33","author":"E Nursoy","year":"2020","unstructured":"Nursoy, E. et al. Research on the effects of levetiracetam in spinal cord injury model in rats: an experimental study. J. Investig. Surg. 33, 252\u2013262 (2020).","journal-title":"J. Investig. Surg."},{"key":"121_CR38","doi-asserted-by":"crossref","first-page":"489","DOI":"10.2165\/11202830-000000000-00000","volume":"71","author":"KA Lyseng-Williamson","year":"2011","unstructured":"Lyseng-Williamson, K. A. Levetiracetam. Drugs 71, 489\u2013514 (2011).","journal-title":"Drugs"},{"key":"121_CR39","doi-asserted-by":"crossref","unstructured":"Assun\u00e7\u00e3o-Silva, R. C., Gomes, E. D., Sousa, N., Silva, N. A. & Salgado, A. J. Hydrogels and cell based therapies in spinal cord injury regeneration. Stem Cells Int. 2015, 24 (2015).","DOI":"10.1155\/2015\/948040"},{"key":"121_CR40","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3390\/ph10040083","volume":"10","author":"R Lima","year":"2017","unstructured":"Lima, R. et al. Systemic interleukin-4 administration after spinal cord injury modulates inflammation and promotes neuroprotection. Pharmaceuticals 10, 83 (2017).","journal-title":"Pharmaceuticals"},{"key":"121_CR41","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.spinee.2016.04.013","volume":"16","author":"NL Vasconcelos","year":"2016","unstructured":"Vasconcelos, N. L. et al. Combining neuroprotective agents: effect of riluzole and magnesium in a rat model of thoracic spinal cord injury. Spine J. 16, 1015\u20131024 (2016).","journal-title":"Spine J."},{"key":"121_CR42","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.expneurol.2018.02.007","volume":"303","author":"MW Urban","year":"2018","unstructured":"Urban, M. W. et al. Cell-type specific expression of constitutively-active Rheb promotes regeneration of bulbospinal respiratory axons following cervical SCI. Exp. Neurol. 303, 108\u2013119 (2018).","journal-title":"Exp. Neurol."},{"key":"121_CR43","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248\u2013254 (1976).","journal-title":"Anal. Biochem."},{"key":"121_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/neu.1995.12.1","volume":"12","author":"DM Basso","year":"1995","unstructured":"Basso, D. M., Beattie, M. S. & Bresnahan, J. C. A sensitive and reliable locomotor rating scale for open field testing in rats. J. Neurotrauma 12, 1\u201321 (1995).","journal-title":"J. Neurotrauma"},{"key":"121_CR45","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1089\/ten.tec.2012.0264","volume":"19","author":"NA Silva","year":"2012","unstructured":"Silva, N. A. et al. Benefits of spine stabilization with biodegradable scaffolds in spinal cord injured rats. Tissue Eng. Part C: Methods 19, 101\u2013108 (2012).","journal-title":"Tissue Eng. Part C: Methods"},{"key":"121_CR46","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0006-8993(00)02778-5","volume":"883","author":"GA Metz","year":"2000","unstructured":"Metz, G. A., Merkler, D., Dietz, V., Schwab, M. E. & Fouad, K. Efficient testing of motor function in spinal cord injured rats. Brain Res. 883, 165\u2013177 (2000).","journal-title":"Brain Res."},{"key":"121_CR47","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/0165-0270(93)90068-3","volume":"46","author":"JA Bertelli","year":"1993","unstructured":"Bertelli, J. A. & Mira, J.-C. Behavioral evaluating methods in the objective clinical assessment of motor function after experimental brachial plexus reconstruction in the rat. J. Neurosci. Methods 46, 203\u2013208 (1993).","journal-title":"J. Neurosci. Methods"},{"key":"121_CR48","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/j.1749-6632.1988.tb38619.x","volume":"525","author":"GG Berntson","year":"1988","unstructured":"Berntson, G. G., Jang, J. F. & Ronca, A. E. Brainstem systems and grooming behaviors a. Ann. N. Y. Acad. Sci. 525, 350\u2013362 (1988).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"121_CR49","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3389\/fnbeh.2017.00145","volume":"11","author":"MM Carvalho","year":"2017","unstructured":"Carvalho, M. M. et al. Effect of levodopa on reward and impulsivity in a rat model of Parkinson\u2019s disease. Front. Behav. Neurosci. 11, 145 (2017).","journal-title":"Front. Behav. Neurosci."},{"key":"121_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-020-01945-8","volume":"17","author":"S Monteiro","year":"2020","unstructured":"Monteiro, S. et al. Splenic sympathetic signaling contributes to acute neutrophil infiltration of the injured spinal cord. J. Neuroinflammation 17, 1\u201314 (2020).","journal-title":"J. Neuroinflammation"},{"key":"121_CR51","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1002\/smll.201201888","volume":"9","author":"SR Cerqueira","year":"2013","unstructured":"Cerqueira, S. R. et al. Microglia response and in vivo therapeutic potential of methylprednisolone\u2010loaded dendrimer nanoparticles in spinal cord injury. Small 9, 738\u2013749 (2013).","journal-title":"Small"}],"container-title":["npj Regenerative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41536-021-00121-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41536-021-00121-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41536-021-00121-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,29]],"date-time":"2023-01-29T14:06:14Z","timestamp":1675001174000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41536-021-00121-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,2]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["121"],"URL":"https:\/\/doi.org\/10.1038\/s41536-021-00121-7","relation":{},"ISSN":["2057-3995"],"issn-type":[{"type":"electronic","value":"2057-3995"}],"subject":[],"published":{"date-parts":[[2021,3,2]]},"assertion":[{"value":"9 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11"}}